Patient Satisfaction in Stroke Patients "PatZuFrie"

Completed

Phase N/A Results N/A

Trial Description

The objective of this trial is to guarantee a follow-up of all stroke and transient ischemic attack (TIA) patients. With this follow-up assessment long term effects of therapy and prevention measures can be detected and monitored. It is part of quality assurance.

Detailed Description

Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness Key secondary endpoint(s): Compliance/adherence with discharge medication. Re-events. Degree of Disability. Activities of daily living. Mortality.

Conditions

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Trial Population

Stroke and TIA patients treated at the Charite with acute stroke or TIA onset less than 7 days

Outcomes

Type Measure Time Frame Safety Issue
Primary Primary efficacy endpoint: Number of patients who state that they received all the information they want about the causes and nature of their illness. September 2010 No
Secondary Compliance/adherence with discharge medication Activities of daily living September 2010 No
Secondary Re-events September 2010 No
Secondary Degree of Disability September 2010 No
Secondary Mortality September 2010 No

Sponsors